Phase 3 Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- Adults between 18 and 50 years old, both men and women, who are experiencing their first episode of optic neuritis (inflammation of the nerve connecting the eye to the brain) in one eye, along with vision loss in that eye.
- People whose vision loss symptoms started within the last 12 days before receiving the first study treatment.
Who may not be able to join:
- People who have any health condition or history of a condition that, in the opinion of the doctor running the trial, could affect the reliability of the study results or put the participant's safety at risk (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 617-928-5886
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of participants achieving at least 15-letter gain from baseline in low contrast visual acuity (LCVA).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.